Insurance barriers limit access to blood cancer drugs
Patients with blood cancers often face major insurance hurdles and significant out-of-pocket costs when trying to access specialty oral anticancer medications, according to a new nationwide study led by researchers at the Perelman School of Medicine at the University of Pennsylvania.
Read original article on Medical Xpress - latest medical and health news stories →Related news
-
Two charged in scheme to sell counterfeit Ozempic—how you can spot fake meds
United Kingdom
-
Precisely timed signals recreate key antibody factory features in human blood cells
United Kingdom
-
Study shows how music may help tackle addiction
United Kingdom
-
HIV patients with cancer must travel farther than others to access clinical trials
United Kingdom
-
AI-guided light analysis could help assess skin cancer and reduce unnecessary biopsies
United Kingdom
-
Is your patient chatting with AI? new tool guides psychiatrists on assessing patients' AI use
United Kingdom
-
Feeling sick may reflect widespread changes in brain activity, mouse study suggests
United Kingdom
-
Biokineticists fight disease using exercise science: How to bring their skills to rural patients
United Kingdom